je.st
news
Survey: Aubagio (Teriflunomide) Trails Gilenya (Fingolimod) for Multiple Sclerosis Treatment
2013-06-01 21:06:44| Biotech - Topix.net
BioTrends Research Group, a research and advisory firm located in Exton, Pennsylvania, finds that more than half of surveyed neurologists have prescribed Aubagio - the second oral disease-modifying agent marketed for the treatment of multiple sclerosis - to at least one of their MS patients at 6 months post-launch. While this represents a ... (more)
Tags: multiple
treatment
survey
trails
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||